Fatal Necrotizing Colitis Following a Foodborne Outbreak of Enterotoxigenic Clostridium perfringens Type A Infection
The DOI matches its Crossref record.
Abstract
BACKGROUND: Enterotoxigenic Clostridium perfringens type A is the third leading cause of foodborne disease in the United States, resulting annually in an estimated 250,000 cases of a typically mild, self-limiting gastrointestinal illness. METHODS: A retrospective cohort study was conducted to determine the cause of a small cluster of cases of gastrointestinal illness, which included cases of severe necrotizing colitis. Participants in the study consisted of residents and staff of a residential care facility for the mentally ill in Oklahoma (n = 20). An inspection of food preparation and food storage areas of the residential care facility was conducted as part of an environmental investigation. The investigation included extensive microbiological and molecular testing of the C. perfringens isolates and tissue specimens collected at autopsy. RESULTS: A total of 7 (3 confirmed and 4 probable) cases of foodborne enterotoxigenic C. perfringens type A were identified (attack rate, 35%) after the consumption of high-risk foods. Three residents developed acute necrotizing colitis; 2 of them died. Each patient with confirmed infection presented with evidence of constipation or fecal impaction. C. perfringens enterotoxin (CPE)-positive C. perfringens type A was cultured on samples from each patient with necrotizing colitis. Although statistical analyses failed to implicate a food source, the isolates carried a chromosomal cpe gene, which supports a foodborne origin. CONCLUSIONS: This study confirms that foodborne CPE-positive C. perfringens type A can affect the colon, resulting in potentially fatal necrotizing colitis. Drug-induced constipation and fecal impaction, resulting in prolonged exposure of the colonic mucosal tissue to C. perfringens type A toxins, contributed to the development of necrotizing colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix669 · Cited by 627
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix959 · Cited by 532
Shogan, B. D., Belogortseva, N., Luong, P. M., Zaborin, A., Lax, S., Bethel, C., Ward, M., Muldoon, J. P., Singer, M., An, G., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010658 · Cited by 399
SCALLAN, E., HOEKSTRA, R. M., MAHON, B. E., JONES, T. F., & GRIFFIN, P. M. (2015) · Epidemiology and Infection · doi:10.1017/s0950268814003185 · Cited by 296
Toxin Plasmids of Clostridium perfringens
Li, J., Adams, V., Bannam, T. L., Miyamoto, K., Garcia, J. P., Uzal, F. A., Rood, J. I., & McClane, B. A. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00062-12 · Cited by 267
Self-citationPathogenicity and virulence of Clostridium perfringens
Mehdizadeh Gohari, I., A. Navarro, M., Li, J., Shrestha, A., Uzal, F., & A. McClane, B. (2021) · Virulence · doi:10.1080/21505594.2021.1886777 · Cited by 256
Self-citationGuideline for the Antibiotic Use in Acute Gastroenteritis
Kim, Y. J., Park, K.-H., Park, D.-A., Park, J., Bang, B. W., Lee, S. S., Lee, E. J., Lee, H.-J., Hong, S. K., & Kim, Y. R. (2019) · Infection & Chemotherapy · doi:10.3947/ic.2019.51.2.217 · Cited by 46
“The side effects were more common when loperamide was used on its own without appropriate antibiotic treatment [93-95].”
Background
Metadata
- Authors
- Bos, J., Smithee, L., McClane, B., Distefano, R. F., Uzal, F., Songer, J. G., Mallonee, S., & Crutcher, J. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-15
- Volume
- 40
- Issue
- 10
- Pages
- e78-e83
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2149753744
- Cited by
- 115
- References
- 0
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.